Mike Polark
Stock Analyst at Baird
(3.32)
# 955
Out of 4,784 analysts
77
Total ratings
48.89%
Success rate
3.43%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Outperform | $252 → $248 | $157.24 | +57.72% | 6 | Feb 11, 2025 | |
| EW Edwards Lifesciences | Downgrades: Underperform | $60 | $70.91 | -15.39% | 4 | Jan 16, 2025 | |
| NVRO Nevro | Maintains: Neutral | $5 → $6 | $5.84 | +2.74% | 10 | Nov 12, 2024 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $100 → $79 | $105.00 | -24.76% | 7 | Nov 1, 2024 | |
| RMD ResMed | Downgrades: Underperform | $180 | $219.94 | -18.16% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $112.26 | - | 1 | Sep 10, 2024 | |
| SYK Stryker | Initiates: Outperform | $405 | $364.50 | +11.11% | 1 | Sep 10, 2024 | |
| LIVN LivaNova | Maintains: Neutral | $55 | $39.13 | +40.56% | 8 | Aug 28, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $487 → $503 | $491.84 | +2.27% | 7 | Jul 19, 2024 | |
| PODD Insulet | Upgrades: Outperform | $200 | $258.75 | -22.71% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $130.82 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $137.80 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $67.74 | +78.62% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $19.28 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $11.77 | +112.40% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $163.55 | +0.89% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $99.36 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | n/a | $87.63 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $11.85 | +9.70% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $7.65 | +174.51% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $223.00 | +12.11% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $1.95 | +2,105.13% | 1 | Sep 2, 2020 |
Inspire Medical Systems
Feb 11, 2025
Maintains: Outperform
Price Target: $252 → $248
Current: $157.24
Upside: +57.72%
Edwards Lifesciences
Jan 16, 2025
Downgrades: Underperform
Price Target: $60
Current: $70.91
Upside: -15.39%
Nevro
Nov 12, 2024
Maintains: Neutral
Price Target: $5 → $6
Current: $5.84
Upside: +2.74%
iRhythm Technologies
Nov 1, 2024
Maintains: Outperform
Price Target: $100 → $79
Current: $105.00
Upside: -24.76%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $219.94
Upside: -18.16%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $112.26
Upside: -
Stryker
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $364.50
Upside: +11.11%
LivaNova
Aug 28, 2024
Maintains: Neutral
Price Target: $55
Current: $39.13
Upside: +40.56%
Intuitive Surgical
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $491.84
Upside: +2.27%
Insulet
May 7, 2024
Upgrades: Outperform
Price Target: $200
Current: $258.75
Upside: -22.71%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $130.82
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $137.80
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $67.74
Upside: +78.62%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $19.28
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $11.77
Upside: +112.40%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $163.55
Upside: +0.89%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $99.36
Upside: -
Jul 6, 2022
Initiates: Underperform
Price Target: n/a
Current: $87.63
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $11.85
Upside: +9.70%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $7.65
Upside: +174.51%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $223.00
Upside: +12.11%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $1.95
Upside: +2,105.13%